{"ticker": "PIRS", "overview": {"cik": "1583648", "ticker": "PVLA", "name": "PALVELLA THERAPEUTICS, INC.", "industry": "Pharmaceutical Preparations", "country": "United States", "sic": "2834", "announcements": [{"form": "144", "date": "2026-10-21", "title": "Notice of proposed sale", "accession": "0001967940-26-000055", "price_sensitive": false}, {"form": "4", "date": "2026-10-14", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-115916", "price_sensitive": false}, {"form": "144", "date": "2026-10-13", "title": "Notice of proposed sale", "accession": "0001967940-26-000053", "price_sensitive": false}, {"form": "4", "date": "2026-09-18", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-108930", "price_sensitive": false}, {"form": "144", "date": "2026-09-16", "title": "Notice of proposed sale", "accession": "0001967940-26-000051", "price_sensitive": false}, {"form": "4", "date": "2026-09-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-108022", "price_sensitive": false}, {"form": "144", "date": "2026-09-11", "title": "Notice of proposed sale", "accession": "0001967940-26-000050", "price_sensitive": false}, {"form": "4", "date": "2026-09-04", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-105494", "price_sensitive": false}, {"form": "144", "date": "2026-09-02", "title": "Notice of proposed sale", "accession": "0001950047-26-008991", "price_sensitive": false}, {"form": "4", "date": "2026-08-20", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-099222", "price_sensitive": false}, {"form": "144", "date": "2026-08-19", "title": "Notice of proposed sale", "accession": "0001967940-26-000044", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001999371-26-018011", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0000921895-26-002180", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-10", "title": "Form SCHEDULE 13G", "accession": "0001137774-26-000180", "price_sensitive": false}, {"form": "S-8", "date": "2026-08-04", "title": "FORM S-8", "accession": "0001104659-26-090394", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-04", "title": "Quarterly report", "accession": "0001193125-26-331574", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-04", "title": "Material event", "accession": "0001193125-26-331556", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-08-03", "title": "Form SCHEDULE 13G", "accession": "0000053417-26-000050", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-07-29", "title": "Form SCHEDULE 13G", "accession": "0002012383-26-002924", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-084620", "price_sensitive": false}, {"form": "144", "date": "2026-07-15", "title": "Notice of proposed sale", "accession": "0001967940-26-000039", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-14", "title": "Material event", "accession": "0001193125-26-303307", "price_sensitive": true}, {"form": "4", "date": "2026-07-01", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-079865", "price_sensitive": false}, {"form": "3", "date": "2026-07-01", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-079863", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-30", "title": "FORM 8-K", "accession": "0001104659-26-079087", "price_sensitive": true}]}, "description": "PIRS trades as PIRS. Privy Trades holds 150 insider filings for the company, from July 2015 to August 2024. Across those, 13 insiders disclosed 13 open-market purchases totalling $3.34M against 7 sales totalling $25.85M. The most recent filing on record is dated 12 December 2024.", "exchange": null, "stats": {"buy_n": 13, "buy_sum": 3341079.35, "sell_n": 7, "sell_sum": 25854491.56, "net": -22513412.209999997, "insiders": 13, "first_date": "2015-07-06", "last_date": "2024-08-12"}, "metrics": {"ticker": "PIRS", "has_prices": false}, "trades": [{"id": "0001437749-24-037353", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "James A. Geraghty", "who_key": "GERAGHTY JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.01, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774924037353/0001437749-24-037353-index.htm", "trade_date": "2024-12-12", "timestamp": "2024-12-12", "mins": 994486}, {"id": "0001437749-24-036916", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Christopher P. Kiritsy", "who_key": "KIRITSY CHRISTOPHER P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774924036916/0001437749-24-036916-index.htm", "trade_date": "2024-12-02", "timestamp": "2024-12-02", "mins": 1008886}, {"id": "0001940272-24-000006", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "adar1 Capital Management, LLC", "who_key": "ADAR1 Capital Management, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 92325.9, "score": 36.9, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whale tops up: $92K of PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000194027224000006/0001940272-24-000006-index.htm", "trade_date": "2024-08-12", "timestamp": "2024-08-12", "mins": 1170166}, {"id": "0001437749-24-032319", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "James A. Geraghty", "who_key": "GERAGHTY JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1.0, "score": 15.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The boardroom is buying: $1 of PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774924032319/0001437749-24-032319-index.htm", "trade_date": "2024-08-07", "timestamp": "2024-08-07", "mins": 1177366}, {"id": "0001437749-23-018278", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Matthew L. Sherman", "who_key": "Sherman Matthew L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923018278/0001437749-23-018278-index.htm", "trade_date": "2023-06-21", "timestamp": "2023-06-21", "mins": 1772086}, {"id": "0001437749-23-018279", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Maya R. Said", "who_key": "Said Maya R.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923018279/0001437749-23-018279-index.htm", "trade_date": "2023-06-21", "timestamp": "2023-06-21", "mins": 1772086}, {"id": "0001437749-23-018280", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Michael Richman", "who_key": "Richman Michael", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923018280/0001437749-23-018280-index.htm", "trade_date": "2023-06-21", "timestamp": "2023-06-21", "mins": 1772086}, {"id": "0001437749-23-018281", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Christopher P. Kiritsy", "who_key": "KIRITSY CHRISTOPHER P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923018281/0001437749-23-018281-index.htm", "trade_date": "2023-06-21", "timestamp": "2023-06-21", "mins": 1772086}, {"id": "0001437749-23-018282", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Peter A. Kiener", "who_key": "Kiener Peter A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923018282/0001437749-23-018282-index.htm", "trade_date": "2023-06-21", "timestamp": "2023-06-21", "mins": 1772086}, {"id": "0001437749-23-018283", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "James A. Geraghty", "who_key": "GERAGHTY JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923018283/0001437749-23-018283-index.htm", "trade_date": "2023-06-21", "timestamp": "2023-06-21", "mins": 1772086}, {"id": "0001437749-23-018284", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Ann Barbier", "who_key": "Barbier Ann", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923018284/0001437749-23-018284-index.htm", "trade_date": "2023-06-21", "timestamp": "2023-06-21", "mins": 1772086}, {"id": "0001562180-23-004575", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Christopher P. Kiritsy", "who_key": "KIRITSY CHRISTOPHER P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8500.0, "score": 41.7, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "3 insiders now buying PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218023004575/0001562180-23-004575-index.htm", "trade_date": "2023-05-25", "timestamp": "2023-05-25", "mins": 1810966}, {"id": "0001437749-23-004940", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Stephen S. Yoder", "who_key": "Yoder Stephen S.", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923004940/0001437749-23-004940-index.htm", "trade_date": "2023-02-24", "timestamp": "2023-02-24", "mins": 1940566}, {"id": "0001437749-23-004948", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Shane Olwill", "who_key": "Olwill Shane", "role": "Chief Development Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923004948/0001437749-23-004948-index.htm", "trade_date": "2023-02-24", "timestamp": "2023-02-24", "mins": 1940566}, {"id": "0001437749-23-004953", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Ahmed Mousa", "who_key": "Mousa Ahmed", "role": "Chief Business Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923004953/0001437749-23-004953-index.htm", "trade_date": "2023-02-24", "timestamp": "2023-02-24", "mins": 1940566}, {"id": "0001437749-23-004958", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Hitto Kaufmann", "who_key": "Kaufmann Hitto", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923004958/0001437749-23-004958-index.htm", "trade_date": "2023-02-24", "timestamp": "2023-02-24", "mins": 1940566}, {"id": "0001437749-23-004963", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Thomas Bures", "who_key": "Bures Thomas", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774923004963/0001437749-23-004963-index.htm", "trade_date": "2023-02-24", "timestamp": "2023-02-24", "mins": 1940566}, {"id": "0001583648-22-000048", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Matthew L. Sherman", "who_key": "Sherman Matthew L", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000048/0001583648-22-000048-index.htm", "trade_date": "2022-06-22", "timestamp": "2022-06-22", "mins": 2296246}, {"id": "0001583648-22-000049", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Michael Richman", "who_key": "Richman Michael", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000049/0001583648-22-000049-index.htm", "trade_date": "2022-06-22", "timestamp": "2022-06-22", "mins": 2296246}, {"id": "0001583648-22-000050", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Christopher P. Kiritsy", "who_key": "KIRITSY CHRISTOPHER P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000050/0001583648-22-000050-index.htm", "trade_date": "2022-06-22", "timestamp": "2022-06-22", "mins": 2296246}, {"id": "0001583648-22-000051", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Peter A. Kiener", "who_key": "Kiener Peter A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000051/0001583648-22-000051-index.htm", "trade_date": "2022-06-22", "timestamp": "2022-06-22", "mins": 2296246}, {"id": "0001583648-22-000052", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "James A. Geraghty", "who_key": "GERAGHTY JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000052/0001583648-22-000052-index.htm", "trade_date": "2022-06-22", "timestamp": "2022-06-22", "mins": 2296246}, {"id": "0001583648-22-000053", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Maya R. Said", "who_key": "Said Maya R.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000053/0001583648-22-000053-index.htm", "trade_date": "2022-06-22", "timestamp": "2022-06-22", "mins": 2296246}, {"id": "0001583648-22-000054", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Ann Barbier", "who_key": "Barbier Ann", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "Director files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000054/0001583648-22-000054-index.htm", "trade_date": "2022-06-22", "timestamp": "2022-06-22", "mins": 2296246}, {"id": "0001583648-22-000030", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Tim Demuth", "who_key": "Demuth Tim", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 10260.0, "score": 31.4, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "4 insiders now buying PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000030/0001583648-22-000030-index.htm", "trade_date": "2022-05-13", "timestamp": "2022-05-13", "mins": 2353846}, {"id": "0001562180-22-001870", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Stephen S. Yoder", "who_key": "Yoder Stephen S.", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CEO files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218022001870/0001562180-22-001870-index.htm", "trade_date": "2022-02-22", "timestamp": "2022-02-22", "mins": 2469046}, {"id": "0001562180-22-001871", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Hitto Kaufmann", "who_key": "Kaufmann Hitto", "role": "SVP, Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218022001871/0001562180-22-001871-index.htm", "trade_date": "2022-02-22", "timestamp": "2022-02-22", "mins": 2469046}, {"id": "0001562180-22-001872", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Thomas Bures", "who_key": "Bures Thomas", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "CFO files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218022001872/0001562180-22-001872-index.htm", "trade_date": "2022-02-22", "timestamp": "2022-02-22", "mins": 2469046}, {"id": "0001562180-22-001873", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Shane Olwill", "who_key": "Olwill Shane", "role": "Chief Development Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218022001873/0001562180-22-001873-index.htm", "trade_date": "2022-02-22", "timestamp": "2022-02-22", "mins": 2469046}, {"id": "0001562180-22-001874", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Ahmed Mousa", "who_key": "Mousa Ahmed", "role": "Chief Business Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "C-suite exec files routine paperwork on PIRS \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218022001874/0001562180-22-001874-index.htm", "trade_date": "2022-02-22", "timestamp": "2022-02-22", "mins": 2469046}], "recent_buys": [{"id": "0001940272-24-000006", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "adar1 Capital Management, LLC", "who_key": "ADAR1 Capital Management, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 92325.9, "score": 36.9, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whale tops up: $92K of PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000194027224000006/0001940272-24-000006-index.htm", "trade_date": "2024-08-12", "timestamp": "2024-08-12", "mins": 1170166}, {"id": "0001437749-24-032319", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "James A. Geraghty", "who_key": "GERAGHTY JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1.0, "score": 15.0, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The boardroom is buying: $1 of PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774924032319/0001437749-24-032319-index.htm", "trade_date": "2024-08-07", "timestamp": "2024-08-07", "mins": 1177366}, {"id": "0001562180-23-004575", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Christopher P. Kiritsy", "who_key": "KIRITSY CHRISTOPHER P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8500.0, "score": 41.7, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "3 insiders now buying PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218023004575/0001562180-23-004575-index.htm", "trade_date": "2023-05-25", "timestamp": "2023-05-25", "mins": 1810966}, {"id": "0001583648-22-000030", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Tim Demuth", "who_key": "Demuth Tim", "role": "Chief Medical Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 10260.0, "score": 31.4, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "4 insiders now buying PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000158364822000030/0001583648-22-000030-index.htm", "trade_date": "2022-05-13", "timestamp": "2022-05-13", "mins": 2353846}, {"id": "0001562180-18-003953", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Christopher P. Kiritsy", "who_key": "KIRITSY CHRISTOPHER P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 25525.000000000004, "score": 47.1, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "5 insiders now buying PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218018003953/0001562180-18-003953-index.htm", "trade_date": "2018-09-14", "timestamp": "2018-09-14", "mins": 4279126}, {"id": "0001562180-18-002509", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "James A. Geraghty", "who_key": "GERAGHTY JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 57500.0, "score": 51.2, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "5 insiders now buying PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218018002509/0001562180-18-002509-index.htm", "trade_date": "2018-05-15", "timestamp": "2018-05-15", "mins": 4454806}, {"id": "0000899243-17-020636", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "James A. Geraghty", "who_key": "GERAGHTY JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 48200.0, "score": 35.3, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying PIRS \u2014 5 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924317020636/0000899243-17-020636-index.htm", "trade_date": "2017-08-17", "timestamp": "2017-08-17", "mins": 4845046}, {"id": "0000899243-17-020635", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Allan Reine", "who_key": "Reine Allan", "role": "See Remarks", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 313350.0, "score": 46.6, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "5 insiders now buying PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924317020635/0000899243-17-020635-index.htm", "trade_date": "2017-08-17", "timestamp": "2017-08-17", "mins": 4845046}, {"id": "0000899243-16-022948", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Louis Matis", "who_key": "Matis Louis", "role": "SVP, Chief Development Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 17037.45, "score": 48.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "That makes 8 insiders into PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924316022948/0000899243-16-022948-index.htm", "trade_date": "2016-06-14", "timestamp": "2016-06-14", "mins": 5462806}, {"id": "0000899243-16-022950", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Darlene M. Deptula-Hicks", "who_key": "DEPTULA-HICKS DARLENE M", "role": "SVP, Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 8300.0, "score": 34.1, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "PIRS draws its 6th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924316022950/0000899243-16-022950-index.htm", "trade_date": "2016-06-13", "timestamp": "2016-06-13", "mins": 5464246}, {"id": "0000899243-16-022949", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Stephen S. Yoder", "who_key": "Yoder Stephen S.", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 10080.0, "score": 37.5, "price_sensitive": false, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "7 insiders pile into PIRS", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924316022949/0000899243-16-022949-index.htm", "trade_date": "2016-06-13", "timestamp": "2016-06-13", "mins": 5464246}, {"id": "0000899243-15-000922", "src": "INSIDERS", "ticker": "PIRS", "cik": "1583648", "company": "PALVELLA THERAPEUTICS, INC.", "company_raw": "PIERIS PHARMACEUTICALS, INC.", "who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 1375000.0, "score": 53.8, "price_sensitive": true, "cluster": 0, "industry": "Pharmaceutical Preparations", "country": "United States", "headline": "The whole bench is buying PIRS \u2014 9 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924315000922/0000899243-15-000922-index.htm", "trade_date": "2015-07-06", "timestamp": "2015-07-06", "mins": 5958166}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Orbimed Advisors LLC", "who_key": "ORBIMED ADVISORS LLC", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 1375000.0, "sold": 19828141.56, "net": -18453141.56, "trades": 5, "top_score": 53.8, "lean": "selling", "history": [{"action": "SELL", "amount": 6350000.0, "date": "2018-04-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000094787118000372/0000947871-18-000372-index.htm"}, {"action": "SELL", "amount": 70915.06, "date": "2018-02-13", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000094787118000156/0000947871-18-000156-index.htm"}, {"action": "SELL", "amount": 12565707.0, "date": "2018-01-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000094787118000012/0000947871-18-000012-index.htm"}, {"action": "SELL", "amount": 841519.5, "date": "2017-12-18", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000094787117001023/0000947871-17-001023-index.htm"}, {"action": "BUY", "amount": 1375000.0, "date": "2015-07-06", "score": 53.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924315000922/0000899243-15-000922-index.htm"}], "latest": {"action": "SELL", "amount": 6350000.0, "date": "2018-04-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000094787118000372/0000947871-18-000372-index.htm"}}, {"who": "Aquilo Capital Management, LLC", "who_key": "Aquilo Capital Management, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 0, "sold": 5605000.0, "net": -5605000.0, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 5605000.0, "date": "2020-07-21", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000159198620000011/0001591986-20-000011-index.htm"}], "latest": {"action": "SELL", "amount": 5605000.0, "date": "2020-07-21", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000159198620000011/0001591986-20-000011-index.htm"}}, {"who": "Chau Quang Khuong", "who_key": "Khuong Chau Quang", "role": "Director, 10% Owner", "person_type": "BOARD", "person_label": "Board", "bought": 1375000.0, "sold": 0, "net": 1375000.0, "trades": 1, "top_score": 53.8, "lean": "buying", "history": [{"action": "BUY", "amount": 1375000.0, "date": "2015-07-06", "score": 53.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924315000921/0000899243-15-000921-index.htm"}], "latest": {"action": "BUY", "amount": 1375000.0, "date": "2015-07-06", "score": 53.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924315000921/0000899243-15-000921-index.htm"}}, {"who": "Allan Reine", "who_key": "Reine Allan", "role": "See Remarks", "person_type": "EXEC", "person_label": "Execs", "bought": 313350.0, "sold": 0, "net": 313350.0, "trades": 1, "top_score": 46.6, "lean": "buying", "history": [{"action": "BUY", "amount": 313350.0, "date": "2017-08-17", "score": 46.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924317020635/0000899243-17-020635-index.htm"}], "latest": {"action": "BUY", "amount": 313350.0, "date": "2017-08-17", "score": 46.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924317020635/0000899243-17-020635-index.htm"}}, {"who": "BVF Partners L P/IL", "who_key": "BVF PARTNERS L P/IL", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 0, "sold": 224969.99999999997, "net": -224969.99999999997, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 224969.99999999997, "date": "2019-09-06", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000092189519002391/0000921895-19-002391-index.htm"}], "latest": {"action": "SELL", "amount": 224969.99999999997, "date": "2019-09-06", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000092189519002391/0000921895-19-002391-index.htm"}}, {"who": "Shane Olwill", "who_key": "Olwill Shane", "role": "Chief Development Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 0, "sold": 196380.0, "net": -196380.0, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 196380.0, "date": "2021-08-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218021005712/0001562180-21-005712-index.htm"}], "latest": {"action": "SELL", "amount": 196380.0, "date": "2021-08-30", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218021005712/0001562180-21-005712-index.htm"}}, {"who": "James A. Geraghty", "who_key": "GERAGHTY JAMES A", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 105701.0, "sold": 0, "net": 105701.0, "trades": 3, "top_score": 51.2, "lean": "buying", "history": [{"action": "BUY", "amount": 1.0, "date": "2024-08-07", "score": 15.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774924032319/0001437749-24-032319-index.htm"}, {"action": "BUY", "amount": 57500.0, "date": "2018-05-15", "score": 51.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000156218018002509/0001562180-18-002509-index.htm"}, {"action": "BUY", "amount": 48200.0, "date": "2017-08-17", "score": 35.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000089924317020636/0000899243-17-020636-index.htm"}], "latest": {"action": "BUY", "amount": 1.0, "date": "2024-08-07", "score": 15.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000143774924032319/0001437749-24-032319-index.htm"}}, {"who": "adar1 Capital Management, LLC", "who_key": "ADAR1 Capital Management, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 92325.9, "sold": 0, "net": 92325.9, "trades": 1, "top_score": 36.9, "lean": "buying", "history": [{"action": "BUY", "amount": 92325.9, "date": "2024-08-12", "score": 36.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000194027224000006/0001940272-24-000006-index.htm"}], "latest": {"action": "BUY", "amount": 92325.9, "date": "2024-08-12", "score": 36.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1583648/000194027224000006/0001940272-24-000006-index.htm"}}], "activity": [], "announcements": [{"form": "144", "date": "2026-10-21", "title": "Notice of proposed sale", "accession": "0001967940-26-000055", "price_sensitive": false}, {"form": "4", "date": "2026-10-14", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-115916", "price_sensitive": false}, {"form": "144", "date": "2026-10-13", "title": "Notice of proposed sale", "accession": "0001967940-26-000053", "price_sensitive": false}, {"form": "4", "date": "2026-09-18", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-108930", "price_sensitive": false}, {"form": "144", "date": "2026-09-16", "title": "Notice of proposed sale", "accession": "0001967940-26-000051", "price_sensitive": false}, {"form": "4", "date": "2026-09-15", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-108022", "price_sensitive": false}, {"form": "144", "date": "2026-09-11", "title": "Notice of proposed sale", "accession": "0001967940-26-000050", "price_sensitive": false}, {"form": "4", "date": "2026-09-04", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-105494", "price_sensitive": false}, {"form": "144", "date": "2026-09-02", "title": "Notice of proposed sale", "accession": "0001950047-26-008991", "price_sensitive": false}, {"form": "4", "date": "2026-08-20", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-099222", "price_sensitive": false}, {"form": "144", "date": "2026-08-19", "title": "Notice of proposed sale", "accession": "0001967940-26-000044", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0001999371-26-018011", "price_sensitive": false}, {"form": "SCHEDULE 13G/A", "date": "2026-08-14", "title": "Form SCHEDULE 13G/A", "accession": "0000921895-26-002180", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-08-10", "title": "Form SCHEDULE 13G", "accession": "0001137774-26-000180", "price_sensitive": false}, {"form": "S-8", "date": "2026-08-04", "title": "FORM S-8", "accession": "0001104659-26-090394", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-04", "title": "Quarterly report", "accession": "0001193125-26-331574", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-04", "title": "Material event", "accession": "0001193125-26-331556", "price_sensitive": true}, {"form": "SCHEDULE 13G", "date": "2026-08-03", "title": "Form SCHEDULE 13G", "accession": "0000053417-26-000050", "price_sensitive": false}, {"form": "SCHEDULE 13G", "date": "2026-07-29", "title": "Form SCHEDULE 13G", "accession": "0002012383-26-002924", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-084620", "price_sensitive": false}, {"form": "144", "date": "2026-07-15", "title": "Notice of proposed sale", "accession": "0001967940-26-000039", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-14", "title": "Material event", "accession": "0001193125-26-303307", "price_sensitive": true}, {"form": "4", "date": "2026-07-01", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-079865", "price_sensitive": false}, {"form": "3", "date": "2026-07-01", "title": "OWNERSHIP DOCUMENT", "accession": "0001104659-26-079863", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-30", "title": "FORM 8-K", "accession": "0001104659-26-079087", "price_sensitive": true}], "performance": {"ticker": "PIRS", "has_prices": false, "summary": null, "buys": [{"who": "ADAR1 Capital Management, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 92325.9, "date": "2024-08-12", "score": 36.9, "ref_price": null, "return": null}, {"who": "GERAGHTY JAMES A", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 1.0, "date": "2024-08-07", "score": 15.0, "ref_price": null, "return": null}, {"who": "KIRITSY CHRISTOPHER P", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 8500.0, "date": "2023-05-25", "score": 41.7, "ref_price": null, "return": null}, {"who": "Demuth Tim", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Medical Officer", "amount": 10260.0, "date": "2022-05-13", "score": 31.4, "ref_price": null, "return": null}, {"who": "KIRITSY CHRISTOPHER P", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 25525.000000000004, "date": "2018-09-14", "score": 47.1, "ref_price": null, "return": null}, {"who": "GERAGHTY JAMES A", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 57500.0, "date": "2018-05-15", "score": 51.2, "ref_price": null, "return": null}, {"who": "GERAGHTY JAMES A", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 48200.0, "date": "2017-08-17", "score": 35.3, "ref_price": null, "return": null}, {"who": "Reine Allan", "person_type": "EXEC", "person_label": "Execs", "role": "See Remarks", "amount": 313350.0, "date": "2017-08-17", "score": 46.6, "ref_price": null, "return": null}, {"who": "Matis Louis", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "SVP, Chief Development Officer", "amount": 17037.45, "date": "2016-06-14", "score": 48.8, "ref_price": null, "return": null}, {"who": "DEPTULA-HICKS DARLENE M", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "SVP, Chief Financial Officer", "amount": 8300.0, "date": "2016-06-13", "score": 34.1, "ref_price": null, "return": null}, {"who": "Yoder Stephen S.", "person_type": "CEO", "person_label": "CEOs", "role": "President and CEO, Director", "amount": 10080.0, "date": "2016-06-13", "score": 37.5, "ref_price": null, "return": null}, {"who": "ORBIMED ADVISORS LLC", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 1375000.0, "date": "2015-07-06", "score": 53.8, "ref_price": null, "return": null}, {"who": "Khuong Chau Quang", "person_type": "BOARD", "person_label": "Board", "role": "Director, 10% Owner", "amount": 1375000.0, "date": "2015-07-06", "score": 53.8, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}